GMO Trust has made important updates to the shareholder fees associated with its GMO Emerging Country Debt Shares Fund. This change, filed on November 4, 2026, is significant for investors as it aims to enhance transparency and reduce costs.

The revisions replace sections of the Summary Prospectus, which was initially dated June 30, 2026, and revised on October 20, 2026. The updated fee structure includes a zero percent purchase premium and a redemption fee of 0.50 percent, aimed at making the fund more attractive to potential investors.

Background

GMO Trust, based in Boston, Massachusetts, is an investment company that focuses on various investment strategies. The company operates under the Central Index Key (CIK) 0000772129. The firm has been active in the investment management space, providing various funds to meet the needs of its clients.

What the Filing Says

The filing states, "The sections appearing on page 1 of the Summary Prospectus captioned 'Shareholder Fees' and 'Example' are replaced in their entirety with the following." The updated fee structure is designed to provide clearer information regarding the costs associated with investing in the fund.

Impact

This update may affect current and prospective investors in the GMO Emerging Country Debt Shares Fund. By lowering the fees, GMO Trust aims to attract more investors, particularly in a competitive market where fee structures play a crucial role in investment decisions.

What's Next

The filing does not say what happens next.